CentreBet
- 2-1: FDA approves Phase 3 trials for obtaining additional information about iPPS effectiveness and safety to assess the benefit versus risk of the therapy and to use this information in the drug’s labeling.
- 1,000-1 FDA rejects Phase 3 trials for iPPS
- 10-1: FDA request further information in relation to specific protocols/data that require another round of review
Disclaimer: No money back guarantees available on the above. Only bet responsible.
CentreBet2-1: FDA approves Phase 3 trials for obtaining...
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $261.4K | 990.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 9445 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |